Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs

The validity of information regarding drug toxicity in humans depends on the quality of the methods and instruments used to assess adverse drug events (ADEs). This study evaluates the quality of instruments used to assess and report ADEs to institutional review boards (IRBs) at US cancer centers. Fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacology and therapeutics 2010-08, Vol.88 (2), p.231-236
Hauptverfasser:	Belknap, S M, Georgopoulos, C H, West, D P, Yarnold, P R, Kelly, W N
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse Drug Reaction Reporting Systems - statistics & numerical data Antineoplastic Agents - adverse effects Biological and medical sciences Causality Clinical trial. Drug monitoring Clinical Trials as Topic Data Interpretation, Statistical Drug toxicity and drugs side effects treatment General pharmacology Humans Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) National Cancer Institute (U.S.) Patients Pharmacology. Drug treatments Research Design Socioeconomic Factors United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!